General Information
Application | Inhibitor |
---|
Description | Ertugliflozin, a potent and selective inhibitor of the sodium-dependent glucose cotransporter 2, is currently in phase 2 trials for the treatment of diabetes mellitus. |
---|---|
Cas NO. | 1210344-57-2 |
Purity | 98 % |
---|---|
Molecular Weight |
436.88 |
Formula | C22H25ClO7 |
Target / IC50 |
hSGLT2 : 0.877 nM |
---|---|
Solubility |
DMSO : 87 mg/ml Water : 87 mg/ml Ethanol : 87 mg/ml |
Storage | -20℃ |
Alias | MK-8835, PF-04971729 |
---|